French National Observatory of Patients With Thymic Epithelial Tumor (RYTHMIC)

May 23, 2023 updated by: Intergroupe Francophone de Cancerologie Thoracique
RYTHMIC (Réseau tumeurs THYMiques et Cancer) is a French nationwide network for TET with the objective of territorial coverage by regional expert centers and systematic discussion of patients management at national tumor board.

Study Overview

Status

Recruiting

Conditions

Detailed Description

RYTHMIC (Réseau tumeurs THYMiques et Cancer) is a nationwide network for TET appointed in 2012 by the French National Cancer Institute. The objectives of the network are management of clinical tumor boards and central pathologic review of all cases. RYTHMIC Tumor Board is based on initial histopathological diagnosis.

RYTHMIC is a comprehensive tool for research:

  • to improve the management of patients
  • to monitor dedicated actions
  • to screen patients for future translational and clinical trials

Study Type

Observational

Enrollment (Anticipated)

3262

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • France
      • Paris, France, 75005
        • Recruiting
        • Paris - Institut Curie
        • Contact:
      • Villejuif, France, 94800
        • Recruiting
        • Villejuif - Institut Gustave Roussy
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients with Thymic Epithelial Tumors

Description

Inclusion Criteria:

  • patient with Thymic Epithelial Tumors

Exclusion Criteria:

  • histology other than Thymic Epithelial Tumors

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
histological type
Time Frame: 5 years
histological type according to the WHO classification 2004/2015
5 years
Masaoka-Koga stage
Time Frame: 5 years
Masaoka-Koga stage
5 years
ITMIG/IASLC 2014/2015 stage
Time Frame: 5 years
ITMIG/IASLC 2014/2015 stage
5 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Questions raised at the national expert multidisciplinary tumor board
Time Frame: 5 years
Diagnosis/Imaging, Surgery, Chemotherapy, Radiotherapy
5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Intergroupe Francophone de Cancerologie Thoracique

Investigators

  • Principal Investigator: Benjamin BESSE, Dr, Villejuif - Gustave Roussy

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2012

Primary Completion (Anticipated)

December 1, 2025

Study Completion (Anticipated)

December 1, 2025

Study Registration Dates

First Submitted

March 22, 2016

First Submitted That Met QC Criteria

March 25, 2016

First Posted (Estimate)

March 31, 2016

Study Record Updates

Last Update Posted (Actual)

May 24, 2023

Last Update Submitted That Met QC Criteria

May 23, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IFCT-1104 RYTHMIC

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Thymic Epithelial Tumor

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lithuania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe